Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis

about

Epigenetics in normal and malignant hematopoiesis: An overview and update 2017.Targeting human SET1/MLL family of proteins.The Histone Methyltransferase Mixed Lineage Leukemia (MLL) 3 May Play a Potential Role on Clinical Dilated Cardiomyopathy

P2860

Q33607609-F978A2EB-1503-4576-A330-EE893A4BDEA2 Q38979643-46065A8A-CE9F-4955-9556-9627236939B5 Q42262138-91FE3BA4-E2D5-4CDF-BB4B-68D173DC069F

P2860

Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis

Item

http://www.wikidata.org/entity/Q36127733

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis

@ast

Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis

@en

type

Item

label

Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis

@ast

Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis

@en

prefLabel

Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis

@ast

Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis

@en

P1476

Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis

@en

P2093

Kelly M Arcipowski

http://www.w3.org/2001/XMLSchema#string

Marinka Bulic

http://www.w3.org/2001/XMLSchema#string

Sandeep Gurbuxani

http://www.w3.org/2001/XMLSchema#string

P2860

Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Initial genome sequencing and analysis of multiple myeloma

Enhancer malfunction in cancer

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes.

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators

Whole-genome analysis informs breast cancer response to aromatase inhibition

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

P304

e0162515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0162515

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan D Licht

P577

2016-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27610619

http://www.w3.org/2001/XMLSchema#string

P932

5017600

http://www.w3.org/2001/XMLSchema#string

Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis

about

P2860

P2860

Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932